Pretreatment integrase strand transfer inhibitor resistance in Tianjin,China

作     者：Huan Xia Zhangwen Ge Defa Zhang Yue Wu Ping Ma 

作者机构：Department of Infectious DiseasesTianjin Second People’s HospitalTianjin 300192China Department of Laboratory MedicineGuizhou Provincial People’s HospitalAffiliated Hospital of Guizhou UniversityGuiyangGuizhou 550499China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2023年第136卷第22期

页      面：2735-2737页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100401[医学-流行病与卫生统计学] 10[医学] 

基　　金：supported by grants from the National Natural Science Foundation of China(Nos.82002136 and 82260658) the Health Science and Technology Project of Tianjin Health Commission(Nos.TJWJ2021MS033,ZC20037) the Tianjin Key Medical Discipline(Specialty)Construction Project(No.TJYXZDXK-059B) the National Major Scientific and Technological Special Project during the Thirteenth Five-year Plan Period(Grant No.2018ZX10302104) the Science and Technology Project of Guizhou Province(qian ke he foundation-ZKgeneral 215) 

主　　题：infection mortality prognosis 

摘      要：Human immunodeficiency virus(HIV)infection is a significant and pressing concern for public health worldwide.[1]Midway through the 1990s,the widespread use of antiretroviral therapy(ART)has resulted in a significant paradigm shift in the management of HIV infection,thereby altering its prognosis from a lifethreatening disease to a chronic and managed health condition.According to previous studies,people who are living with HIV(PLWH)that are on current ART have shown a decrease in both the morbidity and mortality associated with HIV infection,along with a decreased risk of transmitting the virus to others.